These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent?
    Author: Handlin LR, Vacek JL.
    Journal: Postgrad Med; 1994 Mar; 95(4):77-82. PubMed ID: 8121861.
    Abstract:
    There is little question that reperfusion therapy with thrombolytic agents benefits patients who meet the current eligibility requirements and receive therapy shortly after acute myocardial infarction. Less clear is whether this therapy would benefit and be safe for use in patients who are now deemed ineligible to receive it. The authors compare the three available intravenous thrombolytic agents, summarize the risks and benefits associated with thrombolytic therapy in various situations, and make recommendations based on their experience.
    [Abstract] [Full Text] [Related] [New Search]